Bio-Techne Azione

Bio-Techne EV/OCF

Il EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo) di Bio-Techne (TECH) al 23 ago 2026 è 31,20. L'anno precedente, EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo) era 33,25 — una variazione del -6,17% (inferiore).

EV/OCF

31,20

YoY

-6,17%

Ultimo aggiornamento:

EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo) di Bio-Techne ammonta a 2026 31,20 . EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo) di Bio-Techne ammontava a 2025 33,25 . Diminuisce del -6,17% inferiore rispetto all'anno precedente.

La storia di Bio-Techne EV/OCF

  • 3 anni

  • 10 anni

  • 25 anni

  • Max

EV/OCF
Date
EV/OCF
1 gen 2019
53,49 USD
1 gen 2020
46,11 USD
1 gen 2021
26,94 USD
1 gen 2022
28,85 USD
1 gen 2023
37,43 USD
1 gen 2024
31,92 USD
1 gen 2025
33,25 USD
1 gen 2026
31,20 USD
La storia di Bio-Techne EV/OCF
ANNOEV/OCFYoY
31,20-6,17%
33,25+4,17%
31,92-14,73%
37,43+29,73%
28,85+7,12%
26,94-41,58%
46,11-13,81%
53,49-4,41%
55,96-16,05%
66,66+2,29%
65,17-2,79%
67,04+1,58%
66,00
Access this data via the Eulerpool API

Bio-Techne Analisi delle Azioni

Cosa fa Bio-Techne? Bio-Techne Corp is a global company specializing in the research and development of innovative products and solutions in the field of biosciences. The company was founded in 1976 in Minneapolis and was formerly known as Techne Corporation. Since then, it has grown into an internationally renowned company through its numerous acquisitions and mergers. The company is headquartered in Minneapolis, Minnesota, USA. The business philosophy of Bio-Techne Corp is to help bioscientific researchers and clinicians around the world perform their work more effectively, efficiently, and quickly. The company works closely with its customers to provide them with suitable products and services, thereby developing innovative solutions to the challenges in bioscience. Bio-Techne Corp has various business segments, including protein platforms, diagnostics, genetic analysis, clinical controls, cell culture products, and research reagents. Each business segment offers a variety of products and services to support researchers and clinicians in their work. A key business segment of Bio-Techne Corp is the protein platform, which offers a comprehensive range of proteins, antibodies, and corresponding detection reagents. The company is known for its high-quality proteins and antibodies, which contribute to improving the research of diseases such as cancer, diabetes, and neurological and immunological disorders. Another important business segment of Bio-Techne Corp is diagnostics. Here, the company offers a wide range of clinical diagnostic products, such as tests for analyzing urea, creatinine, and bone density. The company's products help clinicians make precise diagnoses and treat patients more effectively. The genetic analysis segment offers DNA sequencing, gene expression, and genome-wide analysis products and services. These tools enable researchers to better understand the functioning of the human body by exploring the underlying genetic changes. The clinical controls segment offers product and service offerings that improve the reliability and accuracy of diagnostic systems. The company works closely with medical facilities to provide diagnostic solutions that deliver fast and accurate results. The cell culture products segment offers a complete range of solutions for cell cultivation and growth. The offering ranges from basic nutrient media and additives to culture vessels and accessories. The company's products enable researchers to culture cells in a controlled environment and under precise conditions. The last segment of Bio-Techne Corp includes research reagents. Here, the company offers a wide range of reagents used for protein, antibody, and cell function analysis and research. The products meet the needs of researchers in modern bioscience. In summary, Bio-Techne Corp is a company specialized in developing innovative solutions in bioscience, advancing science and medicine. With its products and services offered in various sectors, the company successfully helps researchers and clinicians perform their work faster, more effectively, and cost-efficiently. Bio-Techne è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su Bio-Techne azioni

EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo) di Bio-Techne è 31,20 nel 2026.

Il EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo) di Bio-Techne è passato da 33,25 a 31,20, con una variazione del -6,17 %. Il valore è inferiore rispetto all'anno precedente.

Su Eulerpool è possibile consultare lo sviluppo storico completo del Bio-Techne di EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo) dal 2006, con valori annuali, grafici e analisi dettagliate.

EV/FCO confronta il valore d'impresa con il flusso di cassa operativo, misurando quanto gli investitori pagano per unità di contanti generati dalle operazioni.

Per valutare di EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo), è essenziale confrontarlo con i competitor nello stesso settore e industria. Su Eulerpool puoi trovare confronti diretti con l'industria per EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo).

Un 'buono' varia a seconda del settore e della fase di sviluppo dell'azienda. Su Eulerpool puoi confrontare Bio-Techne di EV/FCO (Valore d'Impresa su Flusso di Cassa Operativo) con i competitor del settore e la media industriale per valutare se è attraente.

Access this data via the Eulerpool API

Valutazione — Bio-Techne

Tutte le Metriche Finanziarie — Bio-Techne